KEQU Fundamental Analysis - KEWAUNEE SCIENTIFIC CP

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to KEQU. KEQU was compared to 187 industry peers in the Health Care Equipment & Supplies industry. KEQU has an average financial health and profitability rating. KEQU does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

KEQU had positive earnings in the past year.

In the past year KEQU had a positive cash flow from operations.

In multiple years KEQU reported negative net income over the last 5 years.

The reported operating cash flow has been mixed in the past 5 years: KEQU reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of 9.29%, KEQU belongs to the top of the industry, outperforming 92.51% of the companies in the same industry.

KEQU's Return On Equity of 28.92% is amongst the best of the industry. KEQU outperforms 97.86% of its industry peers.

KEQU has a Return On Invested Capital of 8.29%. This is amongst the best in the industry. KEQU outperforms 88.77% of its industry peers.

Measured over the past 3 years, the Average Return On Invested Capital for KEQU is above the industry average of 7.89%.

		Industry Rank	Sector Rank
ROA	9.29%
ROE	28.92%
ROIC	8.29%

ROA(3y)6.79%

ROA(5y)2.22%

ROE(3y)17.94%

ROE(5y)5.55%

ROIC(3y)9.9%

ROIC(5y)N/A

1.3 Margins

KEQU's Profit Margin of 7.99% is amongst the best of the industry. KEQU outperforms 81.82% of its industry peers.

The Operating Margin of KEQU (6.73%) is better than 74.87% of its industry peers.

KEQU's Gross Margin of 27.02% is on the low side compared to the rest of the industry. KEQU is outperformed by 75.94% of its industry peers.

In the last couple of years the Gross Margin of KEQU has grown nicely.

		Industry Rank	Sector Rank
OM	6.73%
PM (TTM)	7.99%
GM	27.02%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y25.96%

GM growth 5Y12.54%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), KEQU is creating some value.

Compared to 1 year ago, KEQU has more shares outstanding

KEQU has more shares outstanding than it did 5 years ago.

The debt/assets ratio for KEQU is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.99 indicates that KEQU is not a great score, but indicates only limited risk for bankruptcy at the moment.

KEQU has a Altman-Z score of 2.99. This is in the better half of the industry: KEQU outperforms 69.52% of its industry peers.

KEQU has a debt to FCF ratio of 17.20. This is a negative value and a sign of low solvency as KEQU would need 17.20 years to pay back of all of its debts.

The Debt to FCF ratio of KEQU (17.20) is better than 72.19% of its industry peers.

A Debt/Equity ratio of 1.04 is on the high side and indicates that KEQU has dependencies on debt financing.

KEQU has a Debt to Equity ratio of 1.04. This is in the lower half of the industry: KEQU underperforms 78.61% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.04
Debt/FCF	17.2
Altman-Z	2.99

ROIC/WACC0.99

WACC8.39%

2.3 Liquidity

A Current Ratio of 2.16 indicates that KEQU has no problem at all paying its short term obligations.

The Current ratio of KEQU (2.16) is worse than 61.50% of its industry peers.

KEQU has a Quick Ratio of 1.54. This is a normal value and indicates that KEQU is financially healthy and should not expect problems in meeting its short term obligations.

With a Quick ratio value of 1.54, KEQU perfoms like the industry average, outperforming 43.32% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.16
Quick Ratio	1.54

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for KEQU have decreased strongly by -39.73% in the last year.

KEQU shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.78% yearly.

KEQU shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.02%.

Measured over the past years, KEQU shows a small growth in Revenue. The Revenue has been growing by 5.68% on average per year.

EPS 1Y (TTM)-39.73%

EPS 3Y-27.83%

EPS 5Y-18.78%

EPS Q2Q%25.81%

Revenue 1Y (TTM)18.02%

Revenue growth 3Y4.46%

Revenue growth 5Y5.68%

Sales Q2Q%36.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 68.66, KEQU can be considered very expensive at the moment.

Based on the Price/Earnings ratio, KEQU is valued a bit cheaper than the industry average as 66.84% of the companies are valued more expensively.

KEQU's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.30.

		Industry Rank	Sector Rank
PE	68.66
Fwd PE	N/A

4.2 Price Multiples

85.56% of the companies in the same industry are more expensive than KEQU, based on the Enterprise Value to EBITDA ratio.

Based on the Price/Free Cash Flow ratio, KEQU is valued a bit cheaper than the industry average as 76.47% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	44.23
EV/EBITDA	12.02

4.3 Compensation for Growth

KEQU has a very decent profitability rating, which may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

KEQU does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

KEWAUNEE SCIENTIFIC CP

NASDAQ:KEQU (7/16/2025, 4:30:02 PM)

58.36

+0.76 (+1.32%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)06-25 2025-06-25/amc

Earnings (Next)09-09 2025-09-09

Inst Owners42.22%

Inst Owner Change0%

Ins Owners15.99%

Ins Owner Change2.52%

Market Cap172.16M

Analysts82.86

Price TargetN/A

Short Float %2.94%

Short Ratio5.03

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	68.66
Fwd PE	N/A
P/S	0.78
P/FCF	44.23
P/OCF	26.4
P/B	2.83
P/tB	6.05
EV/EBITDA	12.02

EPS(TTM)0.85

EY1.46%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)1.32

FCFY2.26%

OCF(TTM)2.21

OCFY3.79%

SpS74.59

BVpS20.61

TBVpS9.64

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	9.29%
ROE	28.92%
ROCE	10.66%
ROIC	8.29%
ROICexc	8.88%
ROICexgc	11.81%
OM	6.73%
PM (TTM)	7.99%
GM	27.02%
FCFM	1.77%

ROA(3y)6.79%

ROA(5y)2.22%

ROE(3y)17.94%

ROE(5y)5.55%

ROIC(3y)9.9%

ROIC(5y)N/A

ROICexc(3y)12.02%

ROICexc(5y)N/A

ROICexgc(3y)13.16%

ROICexgc(5y)N/A

ROCE(3y)12.97%

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y25.96%

GM growth 5Y12.54%

F-Score5

Asset Turnover1.16

Health

		Industry Rank	Sector Rank
Debt/Equity	1.04
Debt/FCF	17.2
Debt/EBITDA	3.35
Cap/Depr	65.66%
Cap/Sales	1.19%
Interest Coverage	250
Cash Conversion	34.65%
Profit Quality	22.14%
Current Ratio	2.16
Quick Ratio	1.54
Altman-Z	2.99

F-Score5

WACC8.39%

ROIC/WACC0.99

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-39.73%

EPS 3Y-27.83%

EPS 5Y-18.78%

EPS Q2Q%25.81%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)18.02%

Revenue growth 3Y4.46%

Revenue growth 5Y5.68%

Sales Q2Q%36.07%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-3.94%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-68.09%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-64.13%

OCF growth 3YN/A

OCF growth 5YN/A

KEWAUNEE SCIENTIFIC CP (KEQU) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens